Chance to discover and help fund top innovators in healthcare early intrigues investors Print E-mail
By Staff and Wire Reports   
Friday, 23 March 2012 07:48
They may be some of the most talked about market movers today, but companies like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others were once only ideas looking for early investors to back and believe in them. While their technologies were eventually recognized as some of the most compelling and propelled to the public markets, each of their journeys is unique and fascinating to hear.

Next week, the next generation of future market movers--  some of the hottest early stage and emerging growth life sciences, healthcare and biotech innovators will be presenting live to investors who are looking to connect with entreprenuers.

BioMedReports is, once again, a proud sponsor of this year's Life Sciences and Healthcare Venture Summit presented by youngStartup Ventures.

The event is on tap for next week, March 28th in New York City and it has certainly earned its place as the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers.
Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, the Life Sciences and Healthcare Venture Summit is the one event you don't want to miss. While crowdfunding is the rage right now in the angel community, investors still need top innovations and great companies to bring to the public markets.

Joe Benjamin, who has been helping to organize and present the summit for eight years says this venture summit is important to investors. "It offers access to quality deals," explains Benjamin. "It's also a great opportunity to network with fellow investors and see early stage and emerging growth biotech,pharma, med device, diagnostics, healthcare and healthcare IT startups."

Benjamin says they are expecting 70 companies who will be presenting. If you're a company interested in pitching your platform or idea, you'll have to wait until next year since there are no more slots available.

There are still some limited spots for investors, however.

BioMedReports readers who are interested in registering for the event may use the code "biomedreports" to sign up at discount of $150 off the current rates.

You must act fast, however, since late and on-site registrations are priced significantly higher.

Those wishing to take advantage of the opprotunity to access all of the plenary sessions and panels, get involved in networking sessions and access CEOs and Top Innovator presentations may do so at:

We look forward to seeing you there.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus